In the next paragraphs, the mechanisms by which CDK4/6 inhibitors can exert their anti-tumor activities beyond simply enforcing cytostatic growth arrest are highlighted, and the primary and achieved resistance to CDK4/6is is discussed. Here, CDK4 is linked to neoplasm.